INTROdUCTION
Persistent inflammation is a common maladaptive component in the pathogenesis of human diseases. A prime example of this paradigm is inflammatory bowel disease (IBD), a chronic inflammatory process of the intestinal tract that clinically presents as two phenotypic entities: ulcerative colitis (UC) and Crohn's disease (CD). This disorder involves an interaction between environmental factors and inherited susceptibility, and is associated with an increased risk for colorectal cancer [1] .
The regulation of the inflammatory cascade is a complex process in which the transcription factor NF-κB plays a master regulatory role [2] . Consequently, this factor has also been linked to the pathogenesis of several chronic inflammatory conditions in human beings [2] , including IBD [3, 4] . Canonical NF-κB activity is mediated primarily by NF-κB complexes containing the RelA subunit (also known as p65) or its paralog c-Rel. Under basal conditions, these complexes are kept in the cytosol through interactions with the inhibitory IκB proteins. Their activation requires IκB degradation, an event triggered by a critical kinase complex known as IκB kinase that sits at the cross-roads of numerous signaling pathways. After signaling inputs abate, homeostatic mechanisms that restore basal NF-κB activity are essential for the physiologic function of this pathway. The induction of IκB gene expression [5] , or the expression of IκB kinase inhibitory proteins, such as A20 or CYLD [6, 7] , participate in the timely termination of NF-κB activity. The expression of these factors is under the control of NF-κB itself, thus providing negative feedback loops in the pathway. In addition, it has been recognized that ubiquitination and proteasomal degradation of RelA is critical to terminate transcription of a variety of genes [8] [9] [10] [11] [12] [13] . One ligase responsible for these effects contains the scaffold protein Cul2 in association with copper metabolism MURR1 domain containing 1 (COMMD1) [10, 12] , a prototypical member of the COMMD protein family [14] .
In addition to its role in NF-κB regulation [12, 15] , COMMD1 has been implicated in a variety of cellular processes, including copper transport [16] , electrolyte balance [17] [18] [19] , and hypoxia responses [20] . Given these pleotropic functions, it has remained unclear whether this factor plays a physiologically important role in the control of inflammation in vivo and whether it could play a role in chronic inflammatory diseases. Here we report that myeloidspecific deficiency of Commd1 leads to more intense activation of LPS-inducible genes and is associated with more severe inflammation. In addition, we present genetic evidence linking gene variants associated with reduced COMMD1 expression to risk for UC in humans, highlighting the physiologic importance of this gene in immunity and IBD pathogenesis. 
RESUlTS

COMMD1 rePreSSeS PrOiNflAMMAtOry GeNe eXPreSSiON iN MyelOiD CellS
To evaluate the potential role of COMMD1 in inflammation, and given the known embryonic lethality that results from complete Commd1 deficiency in mice [23] , we generated a tissuespecific mouse model of Commd1 deficiency [24] . First [12, 25, 26] , Commd1 deficiency did not alter substantially the phosphorylation or turnover of IκB ( Figure 1A ), but had a profound effect on RelA ubiquitination ( Figure 1B) .
Next, using bone marrow-derived myeloid cells (BMDMs) from the Mye-K/O mice, we assessed the impact of Commd1 on the LPS transcriptional response at a genome-wide level. High-density microarray experiments indicated that 1008 genes were regulated by LPS at least 3fold in two independent series of experiments (Figure 1C, and Supplementary  Tables 1-3 ). In addition, the expression of 225 genes was found to be regulated by Commd1 (Supplementary Tables 1 and 2) . Notably, the vast majority of Commd1-regulated genes (219 of 225) was also regulated by LPS, and only few Commd1 target genes (6 out of 225) were outside the LPS transcriptional response (Supplementary Tables 2 and 3 ). Hierarchical clustering of these 225 genes was used to visualize the pattern of deregulated expression in Commd1-deficient myeloid cells. Both early and late LPS-inducible genes were affected by Commd1 deficiency ( Figure 1D ). In most instances, the changes observed consisted of increased gene expression, which often were noted even at basal levels ( Figure 1E ).
To further understand the effect of Commd1 on gene expression in myeloid cells, we performed a functional analysis using the Kyoto encyclopedia of genes and genomes (KEGG) database. This showed that only 51 genes (23%) participate in immune regulation at early (3h) or late (24h) time points. The degree of overlapping genes is presented in Venn diagram form. (D) Hierarchical cluster analysis of Commd1-regulated genes during the LPS response. Expression levels normalized to basal expression in WT samples is shown as color-coded log 2 -transformed ratios. The gene induction pattern, either early (>3-fold induction at 3h) or late LPS response (>3-fold induction at 24h), is also indicated. The specific effect of Table 4 ), indicating that a large number of Commd1 gene targets in myeloid cells are not known inflammatory regulators ( Figure 1F ). Next, we assessed the contribution of NF-κB regulation to the effects noted in Commd1-deficient myeloid cells. To that end, NF-κB regulation of genes of interest was ascertained through 2 overlapping approaches: first, using a curated database of published NF-κB gene targets (publicly available at www.NF-kB.org), and second, using chromatin immunoprecipitation (ChIP) for RelA followed by sequencing (ChIP-seq) in LPS-stimulated BMDMs [27] . This indicated that only 66 genes regulated by Commd1 (29%) (Supplementary Table 4 ) are known NF-κB or RelA targets, suggesting that a substantial proportion of the effects of Commd1 are either secondary or mediated through other transcriptional regulators. 
COMMD1 eXertS GeNe-SeleCtiVe effeCtS AMONG Nf-κB-reGUlAteD tArGetS
Altogether, these findings suggest a substantial repressive role for Commd1 on the LPS response in myeloid cells and confirmed a negative regulatory role for Commd1 on selected NF-κB -regulated genes. Indeed, quantitative reversetranscription polymerase chain reaction analysis corroborated that certain NF-κB target genes were selectively regulated (for example, Mx1, Cd86 and Sell) (Figure 2A ), whereas others were relatively insensitive to Commd1 deficiency (such as Il6, Tnfaip3 and Mmp13) (Supplementary Figure 2A) . These findings are in line with previous reports of gene-specific effects for COMMD1 in cancer cell lines [12] . Enhanced expression of selected genes that are not directly regulated by NF-κB was confirmed as well ( Figure 2B ). Interestingly, in contrast to these effects, several hypoxiainduced genes were not affected by Commd1 deficiency in BMDMs (Supplementary Figure 2B) , despite its reported role in hypoxia-dependent gene expression [20, 23] . In aggregate, the data indicate that Commd1 primarily exerts a gene-selective repressive function on the LPS response.
MyelOiD DefiCieNCy Of COMMD1 leADS tO eXAGGerAteD iNflAMMAtOry reSPONSeS iN ViVO
In view of the effects of Commd1 on LPS-induced gene expression, we used 2 models to contrast the inflammatory response of Mye-K/O mice and wild-type (WT) littermate controls. First, we used the cecal ligation and puncture (CLP) model of polymicrobial sepsis. Animal survival was compromised in Mye-K/O mice compared with WT controls ( Figure 3A) . In contrast, cultures of peritoneal fluid showed lower bacterial counts in the Mye-K/O mice ( Figure 3B ), indicating that their increased mortality was not caused by greater bacterial load. Rather, after accounting for bacterial invasion (by examining animals with negative bacterial cultures), we found that Mye-K/O mice had increased cytokine expression ( Figure 3C ), suggesting that exaggerated proinflammatory gene expression was responsible for their increased susceptibility to sepsis. Next, animals were challenged directly with intraperitoneal LPS injection. Once more, Mye-K/O mice showed greater mortality ( Figure 3D ) and increased morbidity (Supplementary Figure 3A) . Tissue injury, manifested by lactate dehydrogenase (LDH) release in plasma, also was more pronounced in Mye-K/O mice (Supplementary Figure 3B) which also displayed greater plasma increases of interleukin (Il)6 and tumor necrosis factor (Tnf) ( Figure 3E ). In contrast, plasma levels of the anti-inflammatory cytokine Il10 were comparable with WT. Tissue expression of proinflammatory genes was more pronounced in Mye-K/O mice, as exemplified by Tnf, as well as other proinflammatory genes ( Figure 3F and Supplementary Figure 4) . Altogether, these data indicate that Commd1 deficiency in the myeloid lineage leads to more profound acute inflammatory responses.
reDUCeD eXPreSSiON Of COMMD1 iS A COMMON feAtUre Of iBD
Given the findings made in the Mye-K/O mouse model, we decided to explore whether COMMD1 could play a role in the pathophysiology of inflammatory disorders in human beings, choosing IBD as a disease model. To this end, we evaluated the expression of COMMD1 in IBD patients. We found that COMMD1 messenger RNA (mRNA) levels in colonic endoscopic biopsy specimens were reduced in an Israeli cohort of patients with colitis (n=29, 18 with Crohn's disease and 11 with ulcerative colitis) compared to unaffected controls (n=16; P=0.04) ( Figure 4A , left). This finding was replicated in an independent patient cohort in the United States (P= 0.04, 22 normal controls and 17 patients with IBD, 9 of whom had CD and 8 had UC) (Supplementary Figure 5) . Similarly, we found that COMMD1 mRNA was reduced in circulating leukocytes from IBD patients with active disease (n=12, 9 with CD and 3 with UC) compared with normal individuals (n=14; P=0.001) ( Figure 4A, right) . Moreover, in a murine model of colitis induced by dextran sodium sulfate (DSS) administration, we also observed decreased mRNA and protein expression of Commd1 and other Commd genes in the colon ( Figure 4B and C) . In aggregate, the data indicate that mucosal inflammation is associated with decreased COMMD1 gene expression in clinical and experimental situations. 
GeNetiC VAriANtS ASSOCiAteD WitH DeCreASeD COMMD1 eXPreSSiON Are ASSOCiAteD WitH UC riSK
In view of the reduced expression of COMMD1 in IBD patients, we investigated whether genetic polymorphisms of this gene might affect IBD risk in human beings. Interestingly, genome-wide association studies (GWAS) have linked an intergenic region near COMMD1 to the risk for various inflammatory conditions including IBD ( Figure 4D ) [3, [28] [29] [30] [31] [32] , but the precise gene responsible for these effects remains unknown.
We began by interrogating the most recent meta-analysis of genome-wide association studies (GWAS) for CD and UC [3] by the IIBDGC, which is currently available on the Ricopili server (www.broadinstitute.org/mpg/ricopili/). These data indicated a suggestive association signal with UC for single-nucleotide polymorphisms (SNPs) located just downstream of COMMD1, including rs3943540 (P=7.89 x 10 , odds ratio (OR)=1.104, 95% confidence interval of the OR between 1.06-1.15). Epigenetic analysis in myeloid cells performed by the Encyclopedia of DNA Elements (ENCODE) project [33] , showed that this genomic locus displays features of a gene regulatory region ( Figure 4D and E), such as histone 3 lysine 4 monomethylation (H3K4me1) and lysine 27 acetylation (H3K27Ac), both associated with active enhancers [34] . In agreement with this notion, the SNP and CNV Annotation (SCAN) database [35] indicates that there is a significant eQTL effect of rs921319 on COMMD1 gene expression. To further examine the possibility that these variants have an effect on COMMD1 expression, we conducted cis-eQTL mapping on whole peripheral blood of 2 cohorts (1240 samples previously studied [21] and 891 samples from the Estonian Biobank). Because the SNPs in question were not present in our eQTL data set, we tested rs921320, located in very close proximity to rs921319 and a perfect proxy SNP for rs6545924 (r 2 =0.9, D' =1). We observed a significant eQTL effect of rs921320 on COMMD1 expression, with the same allelic direction for the Dutch and Estonian cohorts (the P values for individual cohorts were 0.057 and 0.0099, respectively; with a weighted Z-method meta-analysis P=0.0033). The A-allele of rs921320, which is linked to the risk allele for rs6545924, was associated with reduced expression of COMMD1 ( Figure 4F ). On the other hand, we did not observe any eQTL effects of rs921320 on the 2 other neighboring genes, B3GNT2 or TMEM17. Altogether, these findings suggest that genetic variation in the 3' region of COMMD1, which has regulatory effects on gene expression, is linked to risk for UC.
MyelOiD Cell DefiCieNCy Of COMMD1 leADS tO MOre SeVere COlitiS
To further examine the possible involvement of COMMD1 in IBD pathogenesis, we began by assessing the in situ expression of this gene in the colon. Immunofluorescence staining of mouse colon tissue showed staining in the epithelium as well as in mononuclear cells in the lamina propria (Supplementary Figure 6) . Furthermore, confocal microscopy images confirmed that Figure 1A ). With this in mind and in view of the known contributions of both epithelial and myeloid cells in the pathogenesis of human and murine colitis [36, 37] , we evaluated the role of this gene in this disease process using both epithelial and myeloid cell-specific knockout mice.
First, we used the DSS model, which triggers colonocyte injury and an innate immune response to luminal bacteria that results in acute colitis. Mye-K/O mice showed more severe disease that WT animals, with excess mortality, more profound weight loss, and worse disease activity ( Figure 5A ). In agreement with this, colon shortening (a macroscopic marker of tissue injury) and histologic evaluation of the colonic mucosa both indicated more damage in Mye-K/O mice ( Figures 5B and C) . In contrast to these results, Commd1 inactivation in the intestinal epithelium did not result in any appreciable alteration of DSS-induced colitis (Supplementary Figure 7) . The more severe inflammatory response in Mye-K/O mice was correlated with greater numbers of CD68 + myeloid cells in the colon as seen by immunohistochemistry (Figures 5D, left panel, and E), and a consistent trend was observed at the mRNA level for the macrophagespecific gene Emr1 (F4/80, Figure 5D , right panel). In addition, Mye-K/O mice showed increased expression of proinflammatory genes, such as Il6 and Il1b ( Figure 5F ). However, myeloid and lymphoid populations in the mesenteric lymph node (MLN) (Supplementary Figure 8 ) and the spleen (not shown), were not significantly different between the groups.
MyelOiD Cell DefiCieNCy Of COMMD1 PrOMOteS COlitiS-DySPlASiA PrOGreSSiON
Further analysis indicated that recurrent DSS administration, which mimics the chronic nature of IBD, also resulted in more severe disease in Mye-K/O mice, manifested as greater weight loss ( Figure 6A ) and more severe anemia ( Figure 6B ). Colonic tissue from these animals also produced greater amounts of several proinflammatory factors such as Tnf ( Figure 6C and S9 ). In addition, azoxymethane (AOM) followed by recurrent DSS treatments was used to examine progression to dysplasia. In this model, Mye-K/O mice also showed more severe disease, as evidenced by more severe colonic shortening, splenomegaly, and histologic distortion of the mucosal architecture ( Figure 6D ). Moreover, after 7 weeks of treatment, Mye-K/O mice had a greater propensity to develop dysplasia, high-grade dysplasia (HGD) or multifocal dysplasia (MFD) as assessed histologically ( Figure 6D ). By 10 weeks, small adenomas could be visualized, but the total number of lesions was not increased in Mye-K/O mice ( Figure 6E ). Nevertheless, only Mye-K/O mice developed proximal colonic tumors and there was a tendency for the tumor burden to be greater in these animals as a result of greater adenoma volume ( Figure 6E ). In colonic tissue, Mye-K/O animals showed greater NF-κB activation as evidenced by the ratio of the transcriptionally active form of RelA (phosphorylated at Ser536) to total RelA. However, STAT3 activation, another pathway known to promote cancer in the context of chronic tissue inflammation [38] , was not altered in these mice ( Figure 6F ). Altogether, these data highlight a role for myeloid cell expression of Commd1 in chronic colonic inflammation and progression to dysplasia. 
dISCUSSION
COMMD1 plays an essential role to restrain the activity of NF-κB, a master regulator of inflammation. Specifically, COMMD1 acts to terminate NF-κB transcriptional activation through the ubiquitin-mediated degradation of NF-κB subunits. A detailed molecular mechanism by which COMMD1 restrains NF-κB has been examined and reported previously [8, 10, 12, 13] . The studies presented here confirm the negative regulatory role of this factor on the NF-κB pathway [10, 12, 13, 15] , and also underscores the gene-selective nature of these effects. Moreover, the studies in this model corroborate that key aspects of the reported mechanism are evident in the knockout mice, namely normal IκB phosphorylation and turnover, but diminished ability to terminate NF-κB transcriptional activity (ie, reduced RelA/p65 ubiquitination). Importantly, this study investigates the physiological relevance of these events in disease pathogenesis. The data indicate that COMMD1 expression in the myeloid compartment plays an important role in the regulation of inflammatory responses in vivo. Given that diverse functions have been reported for this gene [17, [39] [40] [41] , this report fills a critical void by underscoring that COMMD1 participates in immune regulation. In addition, the results also suggest that COMMD1 has broader effects on proinflammatory gene expression programs that might extend beyond the NF-κB pathway. Whether these effects are the result of secondary perturbations or are the result of direct regulation of transcription factor(s) other than NF-κB, should be further examined in the future.
In the context of intestinal inflammation and progression to cancer, previous studies have underscored the importance of epithelial and myeloid cells in these processes [14, 37, 38] . In particular, epithelial intrinsic NF-κB activation has been shown to be a protective response that promotes cell survival and barrier function [42] , and myeloid cell NF-κB activation is important in sustaining the inflammatory response [36] . The increased propensity to inflammation and colitis observed as a result of myeloid cell deficiency of Commd1 is in agreement with this paradigm and suggests that the immune regulatory roles of this gene are physiological. In addition, the increased progression to dysplasia in Mye-K/O mice is in agreement with the role of myeloid cells in promoting tumor growth through various proinflammatory cytokines [43] . In this regard, our model displays increased production of Tnf and greater tissue activation of NF-κB, both of which have been shown to promote cancer progression in the setting of colitis [36, 44] . In addition, we also found no appreciable phenotype of enterocyte-specific deficiency of Commd1, which stands in contrast to other models of disrupted NF-κB activity in the epithelium [36, 42] . This may reflect the fact that unlike other models, cell survival genes are not regulated by COMMD1 in the transcriptome analysis presented here. Furthermore, it suggests that other reported roles of Commd1, such as the regulation of various transport mechanisms, may be more relevant in these cells.
These observations in the animal model, coupled with the finding that genetic variants linked to lower COMMD1 expression also are associated with an increased risk for UC, suggest that this gene participates in the pathogenesis of this disorder in humans. In this context, it is important to note a recent report of a risk association for COMMD7, another member of the COMMD gene family [45] . Moreover, COMMD1 acts in concert with Cul2 to promote RelA ubiquitination [10, 12, 13] , and the CUL2 gene has been linked to IBD susceptibility [46] . Additional studies, including ongoing resequencing efforts, will be required to validate the genetic association seen here with greater statistical confidence. However, the aggregate of our data and published reports suggest the possibility that homeostatic mechanisms that restore NF-κB to its basal state, when decreased, may enhance the risk for IBD.
Our studies also identified that inflammation can lead to suppressed expression of COMMD1, as seen in patients with colitis as well as in animal models. Our data suggest that this is likely the consequence rather than the cause of inflammation in human disease, because this suppression can be induced by inflammation itself in animal studies. The decrease in COMMD1 expression probably plays a physiologic role in the initiation of an appropriate inflammatory response, but in view of the more severe inflammatory responses seen when this gene is deleted in myeloid cells, persistent COMMD1 suppression is probably maladaptive during chronic inflammation. Therefore, this work highlights the need to gain a refined understanding of the molecular events that control COMMD1 gene expression in the setting of inflammation. With this knowledge, we may begin to envision potential interventions that might restore gene expression, which could be tested for their therapeutic potential in chronic inflammatory disorders.
MATERIAlS ANd METHOdS
Human studies: All procedures involving human subjects were reviewed and approved by the respective Institutional Review Boards (at UT Southwestern Medical Center, The Mayo Clinic and Tel-Aviv Sourasky Medical Center). Circulating leukocytes and intestinal biopsies were obtained at the time of endoscopy as part of the patients' ongoing medical care.
Genome-Wide Association Studies and Quantitative Trait Locus Analysis:
Genetic association data were obtained from the 1000 genomes imputed meta-analysis from 15 genome-wide association studies of CD and/or UC conducted by the International IBD Genetic Consortium (IIBDGC) [3] . We conducted cis-expression quantitative trait locus (cis-eQTL) mapping on whole peripheral blood of 2 cohorts: 1240 samples from a previously published study [21] and 891 samples from the Estonian Biobank, both hybridized to Illumina (San Diego, CA) HT12-v3 oligonucleotide arrays using methodology as described in detail elsewhere [22] .
Statistical analysis:
In all graphs, the mean is presented and the error bars correspond to SEM. Statistical comparisons between mean values were performed using a 1-tailed, heteroscedastic, Student t test. For nonparametric variables, the chi-square test was used. Survival curves were examined using the Kaplan-Meier analysis. 
Supplementary materials and methods:
SUPPlEMENTARY MATERIAlS ANd METHOdS
Mouse Strains: Mice were housed in barrier facilities and fed irradiated standard diet. All animal procedures were approved by the Care and Use Committee. The conditional Commd1 allele was recently described [1] . LysM-Cre 'knockin' mice were obtained from the Jackson laboratory (Bar Harbor, ME). Villin-Cre mice were kindly provided by Dr Eric Fearon.
Sepsis Models: Cecal ligation and puncture was performed as previously described [2] . Overall, the surgical time was kept to fewer than 15-20 minutes. After surgery, the mice were housed individually and monitored in a blinded manner (ie, without knowledge of the specific genotypes). This was performed every hour for the first 4-6 hours, then every 2 hours for the next 6 hours, and, finally, every 4-6 hours until the conclusion of the experiment or the need of euthanasia arose (based on morbidity criteria) (Supplementary Table 5 ). For the LPS model, LPS (Escherichia coli 055:B5, Sigma, St. Louis, MO) was diluted in water to 0.2 mg/mL and placed in a water bath sonicator (model FS20, Fisher, Waltham, MA) for 15-30 minutes at room temperature before use. After sonication, the LPS was filtered (0.2 μm pore) and injected intraperitoneally (0.1 mg/mouse). After injection, the mice were monitored similarly for morbidity until the conclusion of the experiment (Supplementary Table 5 ) Bacterial cultures were performed as previously described [3] and tissue RNA was extracted as noted later. Blood also was collected through orbital puncture, and plasma was separated using EDTA (5 mmol/L).
Acute and Chronic DSS-Induced Colitis:
For the acute colitis model, DSS (Fisher) was administered in the drinking water at a concentration of 3 g/dL (3%). Freshly prepared DSS drinking solution was replaced every 5 days. Mice were housed in individual cages and evaluated daily for their weight and the presence of diarrhea or bleeding to calculate a disease activity index (Supplementary Table 6 ), which was based on the scoring system reported by Cooper et al [4] . Evaluation for occult bleeding included Hemoccult testing (Beckman Coulter, Brea, CA). Treatment was given for up to 10 days and animals showing severe distress were euthanized at any point during the experiment.
For the chronic colitis and cancer model, the animals were given azoxymethane intraperitoneally (AOM, 10 mg/kg, Sigma). After 7 days, DSS was given in the drinking water over 4 days at a concentration of 2.5% followed by 10 days of regular water. This was repeated for 3 cycles and at the end of 7 or 10 weeks, the animals were euthanized, and the spleen and colon were harvested. The organ length and weight were determined and the colon was opened along the mesenteric side, and tumors were counted using a dissecting microscope (Zeiss Stemi 2000-C, Jena, Germany). Tumor volumes were calculated using the following formula: (width 2 ) x (height /2).
Histology and Immunohistochemistry:
At the time of euthanasia, the colon was dissected and opened along the mesenteric side. The open colon was transected longitudinally with one half rolled onto itself as a Swiss roll and fixed in 4% paraformaldehyde (in phosphatebuffered saline). After paraffin embedding and sectioning, the tissue was stained with H&E. The second half was used for RNA extraction as described later. A histologic severity index [4] was used to score colonic sections from mice with acute DSS colitis (Supplementary Table 7 ). In chronic colitis/dysplasia models (azoxymethane/DSS at 7 weeks), Swiss-roll sections of the colon were assessed for the presence of architectural distortion, dysplasia, multifocal dysplasia, or high-grade dysplasia according to standard clinical pathology criteria. The number of individual foci was not quantitated by this approach. All histopathologic analyses were performed in a blinded fashion by a gastrointestinal pathologist (S.D.M.). For CD68 staining, a tissue microarray was generated using random colonic tissue cores obtained from blocks previously prepared from mice with acute colitis. After constructing the microarrays, 5 μm sections were subjected to CD68 staining (clone F8-11; Biolegend, San Diego, CA). Staining was performed on a Ventana Benchmark XT Automated IHC Stainer with Mild CC1 (Cell Conditioning 1) and 32 minutes of primary antibody incubation at a 1:25 dilution (in Chemmate Ab diluent, Dako, Carpinteria, CA). The detection was performed with an Ultraview Universal DAB detection Kit (cat. 760-500; Ventana, Tucson, AZ). The slides were counterstained with Mayer's hematoxylin. Images then were analyzed using the ImageJ software (National Institutes of Health, Bethesda, MD) and cell counts were normalized to the surface area using the surface of a microscopic field as a reference. Co-staining for COMMD1 [5] and F4/80 (11-4801; eBioscience, San Diego, CA) was performed using frozen sections of mouse colon tissue embedded in optimum cutting temperature (OCT) using a previously reported protocol.
Multiplex Cytokine Measurements: EDTA-Plasma was separated from blood samples by centrifugation and stored at -80°C. Full-thickness colonic tissue (1 cm of rectum) was harvested form colitic mice and cultured in 12-well cell culture dish with 1mL of complete Dulbecco's modified Eagle medium culture media. The supernatant was collected 24 hours later, centrifuged and stored at -80°C until measurement. Cytokine measurements were performed using Milliplex MAP beads (Millipore) and run on Luminex Magpix with the Luminex xPONENT software (Luminex, Austin, TX). Data analysis was performed using Milliplex Analyst.
Cell Isolation and Cell Culture:
The generation and immortalization of mouse embryo fibroblasts (MEFs) from the Commd1 floxed mouse has been reported previously [6] . These cells were maintained in high-glucose Dulbecco's modified Eagle medium containing 10% fetal calf serum and treated with MG-132 (20 μmol/L for 3 h) for precipitation of ubiquitinated RelA, as described later. BMDMs were generated by isolation of bone marrow cells from long bones, which were cultured in Roswell Park Memorial Institute (RPMI) media supplemented with 10% fetal calf serum, antibiotics (100 µg/mL penicillin G and 100 µg/mL streptomycin), and Fungizone (Fisher), in the presence of granulocyte-macrophage colony-stimulating factor (20 ng/mL; Peprotech, Rocky Hill, NJ). Myeloid differentiation was allowed to proceed for 10 days. In specific experiments, cells were treated with LPS (10 ng/mL, E. coli 026:B6, Sigma). Hypoxia conditions (3% oxygen) were established in HeraCell incubators. Splenocytes, thymocytes, or mesenteric lymph node (MLN) cells were isolated according to standard protocols. Briefly, after removing the respective organs and placing them on a sterile dish containing RPMI, the tissue was manually ground and strained through a 40 μm tissue strainer. After centrifugation (300g for 5 minutes at 4ºC), the cell pellet was resuspended in 2 mL of AmmoniumChloride-Potassium (ACK) buffer (150mM NH 4 Cl, 10mM KHCO 3 , 0.1mM EDTA, pH + 7.2) to lyze red blood cells. After 3 minutes at room temperature, the ACK lysis was neutralized by adding 10 mL of fluorescence-activated cell sorter (FACS ) media buffer (0.01% Sodium azide, 2.5% fetal calf serum in phosphate-buffered saline). This cell suspension was strained again through the tissue strainer to obtain a single-cell suspension, which was pelleted by centrifugation. Gastrointestinal epithelial cells were isolated according to a previously described method [7] . Briefly, the entire colon, small bowel, or stomach was harvested and flushed clean with 1 mmol/L dithiothreitol (DTT) in Krebs-Ringer Bicarbonate (KRB) buffer (10 mmol/L D-Glucose, 0.5 mmol/L MgCl 2, 4.6 mmol/L KCl, 120 mmol/L NaCl, 0.7 mmol/L Na 2 HPO 4 , 1.5 mmol/L NaH 2 PO 4 , 15 mmol/L NaHCO 3 ). The lumen was filled with KRB buffer supplemented with 10 mmol/L EDTA and 1 mmol/L DTT, and both ends were ligated. The ligated colon was placed in a 50mL conical tube with 30 mL of KRB buffer and placed at 37°C for 20 minutes with agitation. The sealed intestinal segment was palpated gently to loosen the cells, then cut on one end to drain the contents a 1.7mL microfuge tube. The cells were collected by centrifugation at 300g for 5 minutes and rinsed once with KRB buffer.
Flow Cytometry: Cells were resuspended in 2 mL of FACS media buffer and the cells from the mesenteric lymph node (MLN) were resuspended in 600 µL. For antibody staining, 100 µL of each cell suspension was incubated on ice with the following primary antibodies: anti-B220-PE (BD Pharmingen, San Jose, CA), anti-CD3-PE (BD Pharmingen), anti-CD4-perCP (BD Pharmingen), anti-CD8a-APC (BD Pharmingen), anti-Ly6G-APC (eBioscience), anti-Ly6C-PerCP-Cy5.5 (eBioscience), anti-CD11C-APC (BD Pharmingen), anti-CD11b-PE (eBioscience), anti-F4/80-FITC (eBioscience) and corresponding isotype controls. After 30 minutes, the cells were pelleted by centrifugation (300g for 5 minutes at 4ºC) and washed twice in 500 µL of FACS media buffer. Flow cytometric analysis was performed using FACSCalibur (BD Biosciences, Mountain View, CA) and analyzed using FlowJo software (version 7.6.5, FlowJo, Ashland, OR).
Protein Extraction, Immunoblotting and Immunoprecipitation: Cell lysate preparation, nuclear extract preparation, immunoprecipitation, denatured immunoprecipitation and immunoblotting were performed as previously described [5, 8, 9] . Protein lysates from mouse tissues were prepared after snap freezing the samples in liquid nitrogen. After mincing with a razor blade, tissue pieces were submerged in lysis buffer (50 mmol/L Tris-Hcl pH + 7.5, 250 mmol/L NaCl, 3 mmol/L EDTA, 3 mmol/L EGTA, 1% Triton X-100, 0.5% NP40, 10% glycerol, 25 mmol/L Na-pyrophosphate) supplemented with protease inhibitor tablets (Roche, San Francisco, CA). Thereafter, tissue homogenization was performed using a 2mL Douncer and a cleared lysate (supernatant after 10,000g centrifugation) was used for further analysis. The following antibodies were used for Western blotting in this study: β-Actin (Sigma, A5441), COMMD1 [5] , COMMD9 [10] , IκB-α (Upstate Biotechnologies, 06-494), phosphor-IκB-α (Cell signaling, 9246), RelA (Santa Cruz Biotechnology, sc-372 and sc-8008), and ubiquitin (Cell Signaling, 3936).
RNA Extraction and Quantitative Real-Time Reverse-Transcription Polymerase Chain
Reaction: In most cases, RNA was extracted using TRIzol (Invitrogen, Grand Island, NY) according to the manufacturer's instructions. In the case of colonic RNA from colitic mice, we obtained better results by first stabilizing the freshly isolated tissue in RNAlater (Qiagen, Hilden, Germany), followed by RNA extraction using the RNeasy chromatography method (Qiagen), according to the manufacturer's instructions. RNA (5 μg) was used for complementary DNA synthesis using the Superscript III strand synthesis system (Invitrogen). Real-time polymerase chain reaction was performed in an Eppendorf real-time polymerase chain reaction system. In most cases, SYBR Greenbased detection (Invitrogen) was used using gene specific primers, as noted in Supplementary Table 8 . Experiments were performed in triplicate, data were normalized to housekeeping genes, and the relative abundance of transcripts was calculated by the comparative ΔΔCt method.
Microarray Analysis:
The primary data for this analysis are available in the Gene Expression Omnibus (GEO) database at National Center for Biotechnology Information (NCBI, Accession GSE53368). The Whole Mouse Genome Oligo Microarray V2 (G4846A, ID 026655, Agilent Technologies; Santa Clara, CA) used in this study contains 44,397 oligonucleotide probes covering the entire murine transcriptome. Synthesis of Cy3-labeled complementary RNA was performed with the Quick Amp Labeling kit, one color (5190-0442, Agilent Technologies) according to the manufacturer's recommendations. Complementary RNA fragmentation, hybridization, and washing steps also were performed exactly as recommended per the One-Color MicroarrayBased Gene Expression Analysis Protocol V5.7. Slides were scanned on the Agilent Micro Array Scanner G2565CA (pixel resolution, 5 µm; bit depth, 20). Data extraction was performed with the Feature Extraction Software V10.7.3.1 by using the recommended default extraction protocol file: GE1_107_Sep09.xml. The singlechannel data generated by the Feature Extraction software were normalized and analyzed in Genespring GX software, version 12.0 (Agilent Technologies). Low expression values were increased to the constant value 15 (defined as the threshold) to minimize falsepositive ratios. Data were log 2 transformed and normalized to 75th percentile of each array according to the standard procedure in Genespring GX.
Only probes referring to transcripts of annotated genes were considered and Agilent probe annotation was used. In cases of multiple probes per gene the value from that probe with the highest arithmetic mean intensity across all 12 hybridizations was selected. Genes were considered as measurable when the arithmetic mean of (antilog 2 -retransformed) intensity values calculated from all 12 samples was greater than 100 and mean intensity in at least 1 of 6 averaged conditions was greater than 50. Entities showing technical impairments were excluded from analyses. By using these criteria, of 44,397 probes, 18,682 probes corresponding to 11,441 genes were selected for further analysis. Genes were considered as regulated by LPS or by Commd1 KO according to the following criteria: the foldchange of mean values in at least 1 of 3 ratios was greater than 3-fold and regulation was consistent with the same trend in each single (nonaveraged) comparison. The following ratios were calculated: Commd1 KO vs WT, LPS 3 hours WT vs WT, LPS 24 hours WT vs WT. In the resulting gene set Commd1-dependent genes were defined by at least 2-fold differences of the following ratios of mean intensity values: deregulated basal expression (ratio Commd1 KO vs WT), deregulated less than 3 hours LPS treatment (Commd1 KO LPS 3 h vs WT LPS 3 h), deregulated less than 24 hours LPS treatment (Commd1 KO LPS 24 h vs WT LPS 24 h). The ratio values of the resulting COMMD1-dependent 225 genes were analyzed by hierarchical cluster analysis using MeV MultiExperimentViewer, version 4.8.1, 2011 (available: www.tm4.org) with cluster settings "average" as linkage method and "Manhattan distance" as distance measure.
Gene function analysis was performed using the DAVID (v6.7) software platform (maintained by National Institute of Allergy and Infectious Disease (NIAID) and available at http://david.abcc.ncifcrf.gov/home.jsp). Functional annotation was performed using the KEGG database (KEGG Mapper v1.6, released October 1, 2013). The regulation of genes of interest by NF-κB was ascertained by comparing each gene to 2 partially redundant data sets: a curated database of published NF-κB gene targets (publicly available and maintained at www.NF-kB.org), and, second, a chromatin immunoprecipitation (ChIP) seq data set of RelAregulated genes in LPS-stimulated BMDMs [11] . (Table S5) The released of cytokines from these tissues into the culture media was evaluated by a multiplex bead-based assay. Marked in green are statistically significant differences between the groups (p value < 0.05). Paralysis, inability to remain upright, shivering, convulsion
SUPPLEMENTARy FIGURES AND TABLES
Total score: Sum of (Domain scores) for each domain in the scoring system Gross bleeding per rectum
Total score: Sum of (Domain scores) for each domain in the scoring system Entire crypt and surface epithelium
Total score: Sum of (Domain score x involvement score) for each domain in the scoring system 
